BPH vs. NVOH

Last updated Apr 2, 2026

Compare and contrast key facts about BP p.l.c. ADRhedged ETF (BPH) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH).

BPH and NVOH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BPH is an actively managed fund by Precidian. It was launched on Jan 3, 2025. NVOH is an actively managed fund by Precidian. It was launched on Jan 2, 2025.

Performance

BPH vs. NVOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BP p.l.c. ADRhedged ETF (BPH) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). The values are adjusted to include any dividend payments, if applicable.

BPH vs. NVOH - Yearly Performance Comparison

	2026 (YTD)	2025
BPH BP p.l.c. ADRhedged ETF	35.03%	6.33%
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF	-24.75%	-42.98%

Returns By Period

In the year-to-date period, BPH achieves a 35.03% return, which is significantly higher than NVOH's -24.75% return.

BPH

• 1D: -1.67%
• 1M: 17.13%
• YTD: 35.03%
• 6M: 37.66%
• 1Y: 38.47%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVOH

• 1D: -1.00%
• 1M: 0.42%
• YTD: -24.75%
• 6M: -34.28%
• 1Y: -46.24%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BPH vs. NVOH - Expense Ratio Comparison

Both BPH and NVOH have an expense ratio of 0.19%, making them cost-effective options compared to the broader market, where average expense ratios typically range from 0.3% to 0.9%.

BPH

BP p.l.c. ADRhedged ETF

NVOH

Novo Nordisk A/S (B Shares) ADRhedged ETF

Return for Risk

BPH vs. NVOH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPH

BPH Risk / Return Rank: 59
BPH Sharpe Ratio Rank: 69
BPH Sortino Ratio Rank: 64
BPH Omega Ratio Rank: 62
BPH Calmar Ratio Rank: 60
BPH Martin Ratio Rank: 40

NVOH

NVOH Risk / Return Rank: 1
NVOH Sharpe Ratio Rank: 1
NVOH Sortino Ratio Rank: 1
NVOH Omega Ratio Rank: 1
NVOH Calmar Ratio Rank: 1
NVOH Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPH vs. NVOH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BP p.l.c. ADRhedged ETF (BPH) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BPH	NVOH	Difference
Sharpe ratio Return per unit of total volatility	1.30	-0.88	+2.18
Sortino ratio Return per unit of downside risk	1.72	-1.14	+2.86
Omega ratio Gain probability vs. loss probability	1.24	0.84	+0.40
Calmar ratio Return relative to maximum drawdown	1.74	-0.89	+2.63
Martin ratio Return relative to average drawdown	4.47	-1.51	+5.98
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BPH vs. NVOH - Sharpe Ratio Comparison

The current BPH Sharpe Ratio is 1.30, which is higher than the NVOH Sharpe Ratio of -0.88. The chart below compares the historical Sharpe Ratios of BPH and NVOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BPH	NVOH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.30	-0.88	+2.18
Sharpe Ratio (All Time) Calculated using the full available price history	1.19	-0.98	+2.17

Correlation

The correlation between BPH and NVOH is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BPH vs. NVOH - Dividend Comparison

BPH's dividend yield for the trailing twelve months is around 1.88%, less than NVOH's 4.56% yield.

	TTM	2025
BPH BP p.l.c. ADRhedged ETF	1.88%	1.74%
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF	4.56%	2.38%

Drawdowns

BPH vs. NVOH - Drawdown Comparison

The maximum BPH drawdown since its inception was -26.32%, smaller than the maximum NVOH drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for BPH and NVOH.

Drawdown Indicators

	BPH	NVOH	Difference
Max Drawdown Largest peak-to-trough decline	-26.32%	-61.60%	+35.28%
Max Drawdown (1Y) Largest decline over 1 year	-22.08%	-53.00%	+30.92%
Current Drawdown Current decline from peak	-3.05%	-60.40%	+57.35%
Average Drawdown Average peak-to-trough decline	-7.52%	-36.02%	+28.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.61%	31.21%	-22.60%

Volatility

BPH vs. NVOH - Volatility Comparison

BP p.l.c. ADRhedged ETF (BPH) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) have volatilities of 8.56% and 8.19%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BPH	NVOH	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.56%	8.19%	+0.37%
Volatility (6M) Calculated over the trailing 6-month period	19.50%	37.53%	-18.03%
Volatility (1Y) Calculated over the trailing 1-year period	29.60%	52.51%	-22.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.79%	51.04%	-22.25%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.79%	51.04%	-22.25%